Fresenius Medical Care Sees U.S. Plans for Kidney Disease as Positive
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
We are actively monitoring the novel coronavirus (COVID-19) pandemic. Learn About the steps that we are taking to protect our patients, employees, physicians, and partners. If you are a patient with questions or concerns, please find additional information at FreseniusKidneyCare.com and AzuraVascularCare.com
Success! The link has been copied to your clipboard.
Our clinical research and pilot programs continue to result in improved quality of life, fewer hospitalizations, reduced health care complications, better patient outcomes, and more efficient care delivery,” said Dr. Frank Maddux, FMCNA Chief Medical Officer and Executive VP, Clinical and Scientific Affairs. “These initiatives help to fulfill our mission to improve the lives of every patient, every day and to lead the industry in advancing the care that’s provided to patients with chronic illnesses.
Highlights of key presentations involving FMCNA’s staff at the NKF 2016 Spring Clinical Meetings include:
Fresenius Medical Care presents the results of research endeavors at the National Kidney Foundation Spring Clinical Meetings each year to further the advancement of the quality of kidney care and improve patient outcomes.
About Fresenius Medical Care North America
Fresenius Medical Care North America is the premier health care company focused on providing the highest quality care to people with renal and other chronic conditions. Through its industry-leading network of dialysis facilities, outpatient cardiac and vascular labs, and urgent care centers, as well as the country’s largest practice of hospitalist and post-acute providers, Fresenius Medical Care provides coordinated health care services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent. As the world’s largest fully integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products, and renal pharmaceuticals. For more information, visit the FMCNA website at www.freseniusmedicalcare.us. For information about patient services, visit www.freseniuskidneycare.com.
About the National Kidney Foundation Spring Clinical Meetings
For 25 years, nephrology healthcare professionals from across the country have come to the National Kidney Foundation (NKF) Spring Clinical Meetings to learn about the newest developments related to all aspects of nephrology practice, network with colleagues, and present their research findings. The NKF Spring Clinical Meetings is designed for meaningful change in the multidisciplinary healthcare teams’ skills, performance, and patient health outcomes. It is the only conference of its kind that focuses on translating science into practice for the entire healthcare team. For more information about the society, visit https://www.kidney.org.